PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsCyclothiazide
Cyclothiazide
Anhydron, Fluidil (cyclothiazide) is a small molecule pharmaceutical. Cyclothiazide was first approved as Anhydron on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. The pharmaceutical is active against solute carrier family 12 member 3. In addition, it is known to target glutamate receptor 3, glutamate receptor 4, glutamate receptor 1, and glutamate receptor 2.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
urogenital diseasesD000091642
cardiovascular diseasesD002318
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Cyclothiazide
Tradename
Company
Number
Date
Products
ANHYDRONEli LillyN-013157 DISCN1982-01-01
1 products
FLUIDILPharmacia & UpjohnN-018173 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
C: Cardiovascular system drugs
C03: Diuretics
C03A: Low-ceiling diuretics, thiazides
C03AA: Thiazides, plain
C03AA09: Cyclothiazide
C03AB: Thiazides and potassium in combination
C03AB09: Cyclothiazide and potassium
HCPCS
No data
Clinical
No data
Drug
General
Drug common nameCyclothiazide
INNcyclothiazide
Description
Cyclothiazide is 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted at positions 3, 5 and 6 by a 2-norbornen-5-yl group, chlorine, and a sulfonamide group, respectively. A thiazide diuretic, it has been used in the management of hypertension and oedema. It has a role as a diuretic and an antihypertensive agent.
Classification
Small molecule
Drug classdiuretics (thiazide derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
NS(=O)(=O)c1cc2c(cc1Cl)NC(C1CC3C=CC1C3)NS2(=O)=O
Identifiers
PDB
CAS-ID2259-96-3
RxCUI
ChEMBL IDCHEMBL61593
ChEBI ID31448
PubChem CID2910
DrugBankDB00606
UNII IDP71U09G5BW (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
GRIA2
GRIA2
Organism
Homo sapiens
Gene name
GRIA2
Gene synonyms
GLUR2
NCBI Gene ID
Protein name
glutamate receptor 2
Protein synonyms
AMPA receptor subunit GluA2, AMPA-selective glutamate receptor 2, GluA2, GluR-B, GluR-K2, Glutamate receptor ionotropic, AMPA 2, glutamate receptor, ionotropic, AMPA 2
Uniprot ID
Mouse ortholog
Gria2 (14800)
glutamate receptor 2 (P23819)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,513 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use